Roche Holding AG

Here is the public summary page for Roche Holding AG. Please login to see the complete information for Roche Holding AG including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Roche Holding AG stacks up relative to its peers.


Darwin Score-3
TickerRO
Latest Price275.00 CHF as of close on 30-Jul-2025
3 Month price range247.20 to 291.80 CHF
Market Capitalisation207.04Bn CHF
CountrySwitzerland
RegionEurope
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryPharmaceuticals
Sub-IndustryPharmaceuticals
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
See More ...
Company URLhttps://www.roche.com
See Darwins Full Analysis for Roche Holding AG

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Roche Holding AG. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-3
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.-2
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+2

Peer Comparison

There are 2 peers of Roche Holding AG.
Asset NameIndustry GroupPerf(20d)%Asset Score
Novartis AG (NOVN)Pharmaceuticals-3.5+26
Roche Holding AG (ROG)Pharmaceuticals-0.2-3

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn